Affiliation:
1. Department of Medicine, National Jewish Health, 1400 Jackson Street, Denver, CO 80206, USA
Abstract
Purpose: Increased type 2 interferon (i.e., IFN-γ) signaling has been shown to be involved in airway inflammation in a subset of asthma patients who often show high levels of airway neutrophilic inflammation and poor response to corticosteroid treatment. How IFN-γ mediates airway inflammation in a mitochondrial dysfunction setting (e.g., Parkin up-regulation) remains poorly understood. The goal of this study was to determine the role of Parkin, an E3 ubiquitin ligase, in IFN-γ-mediated airway inflammation and the regulation of Parkin by IFN-γ. Methods: A mouse model of IFN-γ treatment in wild-type and Parkin knockout mice, and cultured human primary airway epithelial cells with or without Parkin gene deficiency were used. Results: Parkin was found to be necessary for the production of neutrophil chemokines (i.e., LIX and IL-8) and airway neutrophilic inflammation following IFN-γ treatment. Mechanistically, Parkin was induced by IFN-γ treatment both in vivo and in vitro, which was associated with less expression of a Parkin transcriptional repressor Thap11. Overexpression of Thap11 inhibited Parkin expression in IFN-γ-stimulated airway epithelial cells. Conclusions: Our data suggest a novel mechanism by which IFN-γ induces airway neutrophilic inflammation through the Thap11/Parkin axis. Inhibition of Parkin expression or activity may provide a new therapeutic target for the treatment of excessive neutrophilic inflammation in an IFN-γ-high environment.
Funder
National Institutes of Health
Subject
General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)
Reference26 articles.
1. Revisiting Type 2-high and Type 2-low airway inflammation in asthma: Current knowledge and therapeutic implications;Robinson;Clin. Exp. Allergy,2017
2. Mechanisms of non-type 2 asthma;Hudey;Curr. Opin. Immunol.,2020
3. Ricciardolo, F.L.M., Sprio, A.E., Baroso, A., Gallo, F., Riccardi, E., Bertolini, F., Carriero, V., Arrigo, E., and Ciprandi, G. (2021). Characterization of T2-Low and T2-High Asthma Phenotypes in Real-Life. Biomedicines, 9.
4. High IFN-gamma and low SLPI mark severe asthma in mice and humans;Raundhal;J. Clin. Investig.,2015
5. Dual role for CXCR3 and CCR5 in asthmatic type 1 inflammation;Gauthier;J. Allergy Clin. Immunol.,2022